Cargando…
Estimating the effects of second-line therapy for type 2 diabetes mellitus: retrospective cohort study
OBJECTIVE: Metformin is the recommended initial drug treatment in type 2 diabetes mellitus, but there is no clearly preferred choice for an additional drug when indicated. We compare the counterfactual drug effectiveness in lowering glycated hemoglobin (HbA1c) levels and effect on body mass index (B...
Autores principales: | Gottlieb, Assaf, Yanover, Chen, Cahan, Amos, Goldschmidt, Yaara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730938/ https://www.ncbi.nlm.nih.gov/pubmed/29299328 http://dx.doi.org/10.1136/bmjdrc-2017-000435 |
Ejemplares similares
-
Correlates of second-line type 2 diabetes medication selection in the USA
por: Ackermann, Ronald T, et al.
Publicado: (2017) -
Antihyperglycemic Medications: A Claims-Based Estimate of First-line Therapy Use Prior to Initialization of Second-line Medications
por: Tseng, Yi-Ju, et al.
Publicado: (2017) -
Gestational diabetes and long-term risk for dyslipidemia: a population-based historical cohort study
por: Chodick, Gabriel, et al.
Publicado: (2020) -
Serum creatinine levels and risk of incident type 2 diabetes mellitus or dysglycemia in middle-aged Japanese men: a retrospective cohort study
por: Takeuchi, Mamoru, et al.
Publicado: (2018) -
Retrospective cohort study to examine the association between serum amylase and the incidence of type 2 diabetes mellitus, Toranomon Hospital Health Management Center Study 23 (TOPICS 23)
por: Ikeda, Izumi, et al.
Publicado: (2023)